{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:33:57Z","timestamp":1790058837865,"version":"4.0.1"},"reference-count":76,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jinf.2021.05.010","type":"journal-article","created":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T01:40:27Z","timestamp":1621215627000},"page":"27-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Prevalence of aminoglycoside-induced hearing loss in drug-resistant tuberculosis patients: A systematic review"],"prefix":"10.1016","volume":"83","author":[{"given":"Lauren K.","family":"Dillard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo X.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucero Lopez","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M.","family":"Fullerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly","family":"Chadha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2021.05.010_bib0001","series-title":"Rapid Communication: key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR\/RR-TB)","year":"2018"},{"key":"10.1016\/j.jinf.2021.05.010_bib0002","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(18)31644-1","article-title":"Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis","volume":"392","author":"Ahmad","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2021.05.010_bib0003","series-title":"WHO consolidated guidelines on drug-resistant tuberculosis treatment","year":"2019"},{"key":"10.1016\/j.jinf.2021.05.010_bib0004","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S0140-6736(07)60602-3","article-title":"Global burden of childhood hearing impairment and disease control priorities for developing countries","volume":"369","author":"Olusanya","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2021.05.010_bib0005","doi-asserted-by":"crossref","first-page":"S256","DOI":"10.1093\/geront\/gnw033","article-title":"Aging and hearing health: the life-course approach","volume":"56","author":"Davis","year":"2016","journal-title":"Gerontologist"},{"key":"10.1016\/j.jinf.2021.05.010_bib0006","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"Dementia prevention, intervention, and care","volume":"16","author":"Livingston","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2021.05.010_bib0007","series-title":"World report on hearing","year":"2021"},{"key":"10.1016\/j.jinf.2021.05.010_bib0008","series-title":"Global costs of unaddressed hearing loss and cost-effectiveness of interventions: a WHO report","year":"2017"},{"key":"10.1016\/j.jinf.2021.05.010_bib0009","unstructured":"United Nations. Sustainable Development Goals. 2015. https:\/\/www.un.org\/ga\/search\/view_doc.asp?symbol=A\/RES\/70\/1&Lang=E. Date last updated: October 21 2015. Date last accessed: December 15 2020."},{"key":"10.1016\/j.jinf.2021.05.010_bib0010","first-page":"89","article-title":"Rehabilitation is a global health priority","volume":"87","author":"Heinemann","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jinf.2021.05.010_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-Analyses: the PRISMA Statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.jinf.2021.05.010_bib0012","series-title":"Audiologic management of individuals receiving cochleotoxic drug therapy: guidelines","year":"1994"},{"key":"10.1016\/j.jinf.2021.05.010_bib0013","series-title":"Global tuberculosis report","year":"2016"},{"key":"10.1016\/j.jinf.2021.05.010_bib0014","series-title":"Global tuberculosis report","year":"2017"},{"key":"10.1016\/j.jinf.2021.05.010_bib0015","series-title":"Global tuberculosis report","year":"2018"},{"key":"10.1016\/j.jinf.2021.05.010_bib0016","series-title":"Global tuberculosis report","year":"2019"},{"key":"10.1016\/j.jinf.2021.05.010_bib0017","series-title":"Global tuberculosis report","year":"2020"},{"key":"10.1016\/j.jinf.2021.05.010_bib0018","first-page":"1","article-title":"An audiological profile of patients infected with multi-drug resistant tuberculosis at a district hospital in KwaZulu-Natal","volume":"63","author":"Appana","year":"2016","journal-title":"S Afr J Commun Disord"},{"key":"10.1016\/j.jinf.2021.05.010_bib0019","first-page":"1","article-title":"Adverse effects and choice between the injectable agents amikacin and capreomycin in multidrug-resistant tuberculosis","volume":"1","author":"Arnold","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2021.05.010_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6815-7-5","article-title":"Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up","volume":"7","author":"Duggal","year":"2007","journal-title":"BMC Ear Nose Throat Disord"},{"key":"10.1016\/j.jinf.2021.05.010_bib0021","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.ijporl.2015.04.040","article-title":"The occurrence of auditory dysfunction in children with TB receiving ototoxic medication at a TB hospital in South Africa","volume":"79","author":"Ghafari","year":"2015","journal-title":"Int J Pediatr Otolaryngol"},{"key":"10.1016\/j.jinf.2021.05.010_bib0022","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7196\/SAMJ.4964","article-title":"Aminoglycoside-induced hearing loss in HIV-positive and HIV-negative multidrug-resistant tuberculosis patients","volume":"102","author":"Harris","year":"2012","journal-title":"S Afr Med J"},{"key":"10.1016\/j.jinf.2021.05.010_bib0023","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01778-2017","article-title":"Hearing loss with kanamycin treatment for multidrug-resistant tuberculosis in Bangladesh","volume":"51","author":"Heysell","year":"2018","journal-title":"Eur Resp J"},{"key":"10.1016\/j.jinf.2021.05.010_bib0024","first-page":"113","article-title":"Correlation between the length of kanamycin therapy and hearing threshold shift in multidrug resistant tuberculosis (MDR-TB) patients","volume":"5","author":"Irwan","year":"2017","journal-title":"J Res Med Dent Sci"},{"key":"10.1016\/j.jinf.2021.05.010_bib0025","doi-asserted-by":"crossref","first-page":"e28066","DOI":"10.1371\/journal.pone.0028066","article-title":"Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, India","volume":"1","author":"Isaakidis","year":"2011","journal-title":"PloS one"},{"key":"10.1016\/j.jinf.2021.05.010_bib0026","first-page":"905","article-title":"The incidence of amikacin ototoxicity in multidrug-resistant tuberculosis patients","volume":"10","author":"Javadi","year":"2011","journal-title":"Iran J Pharm Res"},{"key":"10.1016\/j.jinf.2021.05.010_bib0027","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1183\/09031936.00184312","article-title":"Amikacin treatment for multidrug resistant tuberculosis: How much monitoring is required?","volume":"42","author":"Melchionda","year":"2013","journal-title":"Eur Res J"},{"key":"10.1016\/j.jinf.2021.05.010_bib0028","doi-asserted-by":"crossref","first-page":"6337","DOI":"10.1128\/AAC.01050-15","article-title":"Amikacin concentrations predictive of ototoxicity in multidrug-resistant tuberculosis patients","volume":"59","author":"Modongo","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2021.05.010_bib0029","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.5588\/ijtld.13.0075","article-title":"High cure rate with standardized short-course multidrug-resistant tuberculosis treatment in Niger: no relapses","volume":"18","author":"Piubello","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jinf.2021.05.010_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1755-7682-5-3","article-title":"Cochleo-vestibular clinical findings among drug resistant tuberculosis patients on therapy: a pilot study","volume":"5","author":"Ramma","year":"2012","journal-title":"Int Arch Med"},{"key":"10.1016\/j.jinf.2021.05.010_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40360-015-0036-7","article-title":"Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort","volume":"16","author":"Sagwa","year":"2015","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.jinf.2021.05.010_bib0032","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jinf.2012.09.002","article-title":"Hearing loss in children treated for multidrug-resistant tuberculosis","volume":"66","author":"Seddon","year":"2013","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2021.05.010_bib0033","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/thoraxjnl-2013-203900","article-title":"High treatment success in children treated for multidrug-resistant tuberculosis: an observational cohort study","volume":"69","author":"Seddon","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.jinf.2021.05.010_bib0034","first-page":"203","article-title":"Audiological evaluation of patients taking kanamycin for multidrug resistant tuberculosis","volume":"28","author":"Sharma","year":"2016","journal-title":"Iran J Otorhinolaryngol"},{"key":"10.1016\/j.jinf.2021.05.010_bib0035","doi-asserted-by":"crossref","first-page":"e01400","DOI":"10.1128\/AAC.01400-16","article-title":"Reduced chance of hearing loss associated with therapeutic drug monitoring of aminoglycosides in the treatment of multidrug-resistant tuberculosis","volume":"61","author":"Van Altena","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2021.05.010_bib0036","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/03005369409077912","article-title":"Feasibility of otoacoustic emission detection followed by ABR as a universal neonatal screening test for hearing impairment","volume":"28","author":"Hunter","year":"1994","journal-title":"Br J Audiol"},{"key":"10.1016\/j.jinf.2021.05.010_bib0037","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1086\/420742","article-title":"Aminoglycoside toxicity: Daily versus thrice-weekly dosing for treatment of mycobacterial diseases","volume":"38","author":"Peloquin","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2021.05.010_bib0038","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1086\/514620","article-title":"The pharmacodynamics of aminoglycosides","volume":"27","author":"Lacy","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2021.05.010_bib0039","doi-asserted-by":"crossref","first-page":"e2739","DOI":"10.1371\/journal.pntd.0002739","article-title":"Long term streptomycin toxicity in the treatment of Buruli ulcer: follow-up of participants in the BURULICO drug trial","volume":"8","author":"Klis","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jinf.2021.05.010_bib0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1590\/S0036-46652006000200008","article-title":"Hearing impairment in patients with tuberculosis from Northeast Brazil","volume":"48","author":"Lima","year":"2006","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.jinf.2021.05.010_bib0041","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5588\/ijtld.20.0217","article-title":"Ototoxicity among multidrug-resistant TB patients: a systematic review and meta-analysis","volume":"25","author":"Wrohan","year":"2021","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.jinf.2021.05.010_bib0042","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1177\/0898264315614006","article-title":"A comparison of self-report and audiometric measures of hearing and their associations with functional outcomes in older adults","volume":"28","author":"Choi","year":"2016","journal-title":"J Aging Health"},{"key":"10.1016\/j.jinf.2021.05.010_bib0043","unstructured":"World Health Organization. Resolution WHA48.9. Prevention of hearing impairment. In: Forty-eighth World Health Assembly, Geneva, 12 May 1995. Twelfth plenary meeting, Committee A. Geneva: World Health Organization. Available from: http:\/\/www.who.int\/pbd\/publications\/wha_eb\/wha48_9\/en\/"},{"key":"10.1016\/j.jinf.2021.05.010_bib0044","unstructured":"World Health Organization. Resolution WHA.70.13. World Health Assembly resolution on prevention of deafness and hearing loss. In: Seventieth World Health Assembly, Geneva, 31 May 2017. Resolutions and decisions, annexes. Available from: https:\/\/apps.who.int\/gb\/ ebwha\/pdf_files\/WHA70\/A70_R13-en.pdf?ua=1."},{"key":"10.1016\/j.jinf.2021.05.010_bib0045","unstructured":"World Health Organization. WHO operational handbook on tuberculosis 2020. Module 4: treatment. Drug-resistant tuberculosis treatment."},{"key":"10.1016\/j.jinf.2021.05.010_bib0046","series-title":"Introduction of Bedaquiline for the treatment of multidrug-resistant tuberculosis at country level. Implementation plan","year":"2015"},{"key":"10.1016\/j.jinf.2021.05.010_bib0047","series-title":"Community\u2013based rehabilitation promoting ear and hearing care through CBR","year":"2012"},{"key":"10.1016\/j.jinf.2021.05.010_bib0048","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1177\/0194599818782444","article-title":"Progressive hearing loss among patients with cystic fibrosis and parenteral aminoglycoside treatment","volume":"159","author":"Zettner","year":"2018","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jinf.2021.05.010_bib0049","series-title":"Active tuberculosis drug-safety monitoring and management (aDSM): framework for implementation","year":"2015"},{"key":"10.1016\/j.jinf.2021.05.010_bib0050","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1177\/0194599813505972","article-title":"Survey of otolaryngology services in Central America: need for a comprehensive intervention","volume":"149","author":"Wagner","year":"2013","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jinf.2021.05.010_bib0051","series-title":"Multi-country assessment of national capacity to provide hearing care","year":"2013"},{"key":"10.1016\/j.jinf.2021.05.010_bib0052","doi-asserted-by":"crossref","DOI":"10.1080\/16549716.2017.1289736","article-title":"Survey of ear, nose and throat services in sub-Saharan Africa: little progress between 2009 and 2015","volume":"10","author":"Mulwafu","year":"2017","journal-title":"Glob Health Action"},{"key":"10.1016\/j.jinf.2021.05.010_bib0053","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1017\/S0022215117002134","article-title":"Survey of otolaryngology services in Ukraine and neighboring Central and Eastern European countries","volume":"131","author":"Verkerk","year":"2017","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.jinf.2021.05.010_bib0054","first-page":"2141","article-title":"Ototoxicity in tuberculosis treatment in South Africa: exploring the current status","volume":"7","author":"Khoza-Shangase","year":"2013","journal-title":"Afr J Pharm Pharmacol"},{"key":"10.1016\/j.jinf.2021.05.010_bib0055","first-page":"1","article-title":"Ototoxicity management: An investigation into doctors' knowledge and practices, and the roles of audiologists in a tertiary hospital","volume":"63","author":"Wirum","year":"2016","journal-title":"S Afr J Comm Dis"},{"key":"10.1016\/j.jinf.2021.05.010_bib0056","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1080\/14992027.2018.1460495","article-title":"Current practice of ototoxicity management across the United Kingdom","volume":"57","author":"Maru","year":"2018","journal-title":"Int J Audiol"},{"key":"10.1016\/j.jinf.2021.05.010_bib0057","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/010503901750166781","article-title":"Audiology in Latin America: hearing impairment, resources and services","volume":"30","author":"Madriz","year":"2001","journal-title":"Scand Audiol"},{"key":"10.1016\/j.jinf.2021.05.010_bib0058","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2471\/BLT.18.224659","article-title":"Training for hearing care providers","volume":"97","author":"Bhutta","year":"2019","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jinf.2021.05.010_bib0059","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/AUD.0000000000001007","article-title":"Ear and hearing care workforce: current status and its implications","volume":"42","author":"Kamenov","year":"2021","journal-title":"Ear Hear"},{"key":"10.1016\/j.jinf.2021.05.010_bib0060","series-title":"Task shifting: Global recommendations and guidelines","year":"2008"},{"key":"10.1016\/j.jinf.2021.05.010_bib0061","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103754","article-title":"Task shifting for non-communicable disease management in low and middle income countries: a systematic review","volume":"9","author":"Joshi","year":"2014","journal-title":"PloS ONE"},{"key":"10.1016\/j.jinf.2021.05.010_bib0062","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1056\/NEJMra1111610","article-title":"Global supply of health professionals","volume":"370","author":"Crisp","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2021.05.010_bib0063","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/S0140-6736(10)61854-5","article-title":"Health professionals for a new century: transforming education to strengthen health systems in an interdependent world","volume":"376","author":"Frenk","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2021.05.010_bib0064","series-title":"Primary ear and hearing care training resource","year":"2006"},{"key":"10.1016\/j.jinf.2021.05.010_bib0065","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/infdis\/165.6.1026","article-title":"High-frequency audiometric monitoring for early detection of aminoglycoside ototoxicity","volume":"165","author":"Fausti","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2021.05.010_bib0066","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jcf.2014.07.009","article-title":"High-frequency audiometry reveals high prevalence of aminoglycoside ototoxicity in children with cystic fibrosis","volume":"14","author":"Al-Malky","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jinf.2021.05.010_bib0067","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/AUD.0000000000000536","article-title":"Long-term variability of distortion-product otoacoustic emissions in infants and children and its relation to pediatric ototoxicity monitoring","volume":"41","author":"Konrad-Martin","year":"2020","journal-title":"Ear Hear"},{"key":"10.1016\/j.jinf.2021.05.010_bib0068","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/14992020400050072","article-title":"Self-reported outcomes of aural rehabilitation in a developing country","volume":"43","author":"Olusanya","year":"2004","journal-title":"Int J Audiol"},{"key":"10.1016\/j.jinf.2021.05.010_bib0069","first-page":"5","article-title":"Self-reported outcomes of aural rehabilitation for adult hearing aid users in a South African context","volume":"57","author":"Pienaar","year":"2010","journal-title":"S Afr J Comm Dis"},{"key":"10.1016\/j.jinf.2021.05.010_bib0070","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ijporl.2005.08.009","article-title":"Challenges in management of childhood sensorineural hearing loss in sub-Saharan Africa, Nigeria","volume":"70","author":"Lasisi","year":"2006","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.jinf.2021.05.010_bib0071","series-title":"Preferred profile for hearing-aid technology suitable for low- and middle-income countries","year":"2017"},{"key":"10.1016\/j.jinf.2021.05.010_bib0072","series-title":"Audiology in developing countries","first-page":"155","article-title":"Hearing aid provision in developing countries: an Indian case study","author":"Basavaraj","year":"2008"},{"key":"10.1016\/j.jinf.2021.05.010_bib0073","series-title":"Audiology in developing countries","first-page":"141","article-title":"Rehabilitation of hearing loss: Challenges and opportunities in developing countries","author":"Brouillette","year":"2008"},{"key":"10.1016\/j.jinf.2021.05.010_bib0074","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/15257401040250040601","article-title":"A fair hearing for all: providing appropriate amplification in developing countries","volume":"25","author":"McPherson","year":"2004","journal-title":"Commun Disord Q"},{"key":"10.1016\/j.jinf.2021.05.010_bib0075","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/20469047.2016.1276119","article-title":"Solar-powered hearing aids for children with impaired hearing in Vietnam: a pilot study","volume":"38","author":"Vo","year":"2018","journal-title":"Paediatr Int Child Health"},{"key":"10.1016\/j.jinf.2021.05.010_bib0076","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3109\/17483107.2014.905642","article-title":"Technology for hearing loss\u2013as we know it, and as we dream it","volume":"9","author":"Clark","year":"2014","journal-title":"Disabil Rehabil Assist"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445321002528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445321002528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:33:15Z","timestamp":1759008795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445321002528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0163445321002528"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2021.05.010","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of aminoglycoside-induced hearing loss in drug-resistant tuberculosis patients: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2021.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}]}}